Clinical Trial Update: Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on the pharmacokinetics and safety of the hepatitis C drug combination glecaprevir/pibrentasvir in pregnant women, with or without HIV, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Glecaprevir/pibrentasvir (glecaprevir/pibrentasvir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: RECRUITING